Amlodipine Cost in Alabama 2026: Cash Price, Medicaid, Insurance, and Compounding

What Does Amlodipine Actually Cost in Alabama in 2026?

Generic amlodipine retails for approximately $8 per month at Alabama pharmacies when purchased with a discount card such as GoodRx or Costco Health. The Pfizer brand Norvasc carries a list price near $80 per month, but almost no cash-pay patient in Alabama needs to pay that figure given generic availability since 2007. Dose and quantity drive the final number: a 30-tablet supply of amlodipine 5 mg at Walmart Pharmacy in Birmingham regularly prices at $4 through the Walmart Rx program.

Amlodipine belongs to the dihydropyridine calcium channel blocker class. The FDA approved the original Norvasc formulation in 1992 for hypertension and chronic stable angina. [1] Because the molecule is off-patent and manufactured by dozens of generic producers, retail competition keeps prices low. A 90-day supply (90 tablets of 10 mg) at CVS or Walgreens in Huntsville or Mobile typically runs $18 to $24 without any discount card, and drops to $10 to $15 with one. [2]

Price variation across Alabama counties is real but moderate. Rural counties in the Black Belt region may have fewer competing pharmacies, which can push cash prices slightly higher, yet GoodRx and similar programs largely erase that geographic gap by negotiating rates directly with pharmacy benefit managers. [3]

Patients filling at independent pharmacies should always ask the pharmacist to run the prescription through a discount card before ringing up the retail price, since the discount-card price is often lower than the pharmacy's own cash price by 30 to 60 percent. [4]

Alabama Medicaid and Amlodipine: What the PDL Actually Says

Alabama Medicaid does not list amlodipine on its current preferred drug list (PDL) for the hypertension or angina categories. That means a standard Medicaid claim for amlodipine will be denied at the pharmacy counter without a prior authorization. [5]

This is a clinically significant gap. Hypertension affects roughly 36 percent of Alabama adults, one of the highest state prevalences in the country according to CDC surveillance data. [6] Guidelines from the American College of Cardiology and the American Heart Association (2018 ACC/AHA Hypertension Guidelines) specifically recommend dihydropyridine calcium channel blockers such as amlodipine as a first-line agent alongside thiazide diuretics and ACE inhibitors or ARBs for most hypertensive adults. [7]

Alabama Medicaid members who want amlodipine covered have three options. First, their prescribing physician can submit a prior authorization citing medical necessity, particularly if the patient has tried and failed a PDL-preferred agent. Second, the patient can use a cash-pay discount card, since the $8 retail price may be affordable even for Medicaid-eligible patients. Third, a 503A compounding pharmacy licensed in Alabama may provide the compound at no direct cost to the patient under certain patient-assistance arrangements, though this path requires a valid prescription. [8]

The Alabama Medicaid Agency updates its PDL quarterly. Providers and patients should verify current coverage at the Alabama Medicaid Agency website before assuming denial is permanent.

How Alabama Medicaid Prior Authorization Works for Amlodipine

A prior authorization (PA) for amlodipine under Alabama Medicaid requires the prescribing provider to document that a PDL-preferred antihypertensive was tried and either caused intolerable side effects or failed to control blood pressure to goal. [5] The 2018 ACC/AHA guidelines define hypertension as systolic blood pressure at or above 130 mmHg or diastolic at or above 80 mmHg, and set a treatment goal of <130/80 mmHg for most adults. [7]

The PA form must specify the patient's current blood pressure readings, the preferred agent used, the duration of that trial (generally at least 30 days for a stable dose), and the clinical reason amlodipine is preferred. Providers at federally qualified health centers (FQHCs) in Alabama may find the PA process faster through their in-house pharmacy staff, who often maintain standing templates for common requests. [9]

Approval timelines run 24 to 72 hours for standard PAs and can be expedited to same-day for urgent clinical situations. If the PA is approved, Medicaid reimburses at the state's maximum allowable cost (MAC) rate for generic amlodipine, which in 2024 was set below $0.20 per tablet for the 5 mg strength. [5]

Is Compounded Amlodipine Legal in Alabama?

Yes. Alabama permits 503A compounding pharmacies to prepare amlodipine compounds for individual patients when a valid patient-specific prescription exists and the compound addresses a documented clinical need not met by the commercially available tablet. [10]

Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies that prepare medications for individual patients rather than in bulk for office stock. [11] Alabama State Board of Pharmacy regulations align with federal 503A requirements, meaning a licensed Alabama pharmacy operating under 503A may legally compound amlodipine in alternative dose strengths, alternative base formulations (such as an oral suspension for pediatric patients or patients with dysphagia), or combined with another agent in a single preparation. [10]

The clinical use case most relevant to HealthRX patients is combination compounding. A prescriber might order amlodipine 5 mg combined with lisinopril 10 mg in a single capsule to reduce pill burden, which is not commercially available in that exact pairing. [12] The FDA's guidance on 503A compounding specifies that compounded preparations may not be copies of commercially available drugs unless there is a change that produces a clinical difference, so a plain 5 mg amlodipine tablet compound is permissible only when the patient cannot use the commercial tablet. [11]

Compounded amlodipine through a qualifying 503A pharmacy linked to patient-assistance programs has been listed at $0 per month for eligible patients, making it the lowest-cost option in Alabama for those who qualify. Eligibility criteria vary by program and are set by the dispensing pharmacy or its partnered prescriber network.

Amlodipine and Private Insurance in Alabama

Most commercial insurance plans operating in Alabama, including Blue Cross Blue Shield of Alabama, UnitedHealthcare, Humana, and Cigna plans sold on the ACA marketplace, place generic amlodipine on Tier 1 of their formularies. [13] Tier 1 copays in Alabama ACA plans averaged $5 to $10 per 30-day supply in 2025, making insured patients' out-of-pocket cost comparable to or even higher than the uninsured GoodRx price.

This creates a counterintuitive situation. An Alabama resident with a $10 Tier 1 copay on their commercial plan may pay more than an uninsured neighbor using a $4 discount card at Walmart. Pharmacists are legally permitted to tell patients about lower-cost alternatives, though not all do so proactively. [4]

Medicare Part D plans available in Alabama also generally place generic amlodipine on Tier 1. Under the Inflation Reduction Act's 2025 changes to Part D cost-sharing, out-of-pocket costs for Tier 1 generics in the initial coverage phase are typically $0 to $5 per fill for most Alabama Medicare beneficiaries. [14] Patients in the low-income subsidy (LIS or Extra Help) program pay $0 to $4 per fill regardless of plan tier structure. [14]

The brand Norvasc (Pfizer) is rarely covered at a favorable tier by Alabama insurers in 2026. Patients seeking the brand name can apply for Pfizer's patient-assistance program, but the prescriber must document that generics are not appropriate for the patient. [2]

ASCOT-BPLA and Why Amlodipine Became First-Line Therapy

Amlodipine's position as a first-line antihypertensive is grounded in a large outcome trial, not just blood pressure numbers. ASCOT-BPLA (Anglo-Scandinavian Cardiac Outcomes Trial, Blood Pressure Lowering Arm), published in The Lancet in 2005 (N=19,257), compared amlodipine-based therapy (amlodipine plus perindopril as needed) against atenolol-based therapy (atenolol plus bendroflumethiazide as needed) in hypertensive adults with at least three additional cardiovascular risk factors. [15]

The trial was stopped early at a median follow-up of 5.5 years because the amlodipine arm showed significantly lower rates of all-cause mortality (hazard ratio 0.89 to 95% CI 0.81 to 0.99, P=0.025), total cardiovascular events and procedures (HR 0.84, P<0.0001), and fatal plus non-fatal stroke (HR 0.77, P=0.0003). [15] The 23 percent reduction in stroke is one of the largest seen in a head-to-head antihypertensive trial of this scale.

The 2018 ACC/AHA Hypertension Guidelines cite ASCOT-BPLA directly when recommending calcium channel blockers as a preferred first-line drug class: "Thiazide-type diuretics, CCBs, ACEIs, or ARBs are recommended as first-line therapy for the general non-Black and Black hypertensive population." [7] Alabama physicians prescribing amlodipine are following evidence-based guidance with over two decades of supporting outcomes data.

Pfizer Patient-Assistance and Generic Savings Cards in Alabama

Pfizer offers the Norvasc Savings Card for commercially insured patients who meet income and insurance criteria. Under standard program terms, eligible patients may pay as little as $4 per fill for brand-name Norvasc. Alabama residents can apply through Pfizer's website or ask their prescribing physician's office to process the enrollment. [2]

For patients on Medicare or Medicaid, the Pfizer savings card does not apply. Federal anti-kickback laws prohibit manufacturer copay cards from reducing cost-sharing on government insurance programs. [16] Those patients should instead look at the Extra Help/LIS program through Social Security Administration (for Medicare patients) or request a prior authorization for generic amlodipine through Alabama Medicaid.

Generic amlodipine manufacturers, including Mylan, Teva, and Zydus, do not typically offer branded savings cards, but GoodRx, RxSaver, and NeedyMeds function as discount intermediaries that can reduce generic amlodipine to $4 to $8 per month at most Alabama chains. [3] NeedyMeds also maintains a database of state pharmaceutical assistance programs, though Alabama does not operate a standalone state pharmaceutical assistance program (SPAP) for amlodipine as of 2026. [17]

Telehealth Prescribing of Amlodipine in Alabama

Alabama law permits telehealth prescribing of amlodipine by a licensed Alabama physician or advanced practice provider who has established a valid patient-provider relationship. [18] Amlodipine is a Schedule-uncontrolled medication, so none of the additional telehealth prescribing restrictions that apply to controlled substances (such as the DEA's special registration requirements) apply here.

A telehealth visit for hypertension management in Alabama typically involves reviewing home blood pressure logs, current medications, laboratory values (metabolic panel, kidney function), and cardiovascular risk factors. The provider can issue a new prescription or refill electronically to any Alabama pharmacy or to a mail-order pharmacy licensed to dispense in Alabama. [18]

The Alabama Board of Medical Examiners clarified in 2021 that prescribing based solely on an online questionnaire without a synchronous audio-video encounter does not satisfy the patient-provider relationship requirement. [18] An asynchronous questionnaire-only encounter is therefore not sufficient for a first-time amlodipine prescription. Established patients with existing chart documentation may be managed more flexibly at the provider's discretion.

HealthRX telehealth visits include a synchronous video consultation with a licensed provider, satisfying Alabama's relationship requirement, and can result in an amlodipine prescription sent directly to the patient's preferred Alabama pharmacy.

Side Effects That Alabama Patients Most Commonly Report

Amlodipine's most frequent side effect is peripheral edema, reported in 10.8 percent of patients taking 10 mg daily versus 1.5 percent on placebo in the original approval studies. [1] The edema is dose-dependent: patients on 5 mg daily report edema rates closer to 3 percent. [1] Peripheral edema from amlodipine is caused by precapillary vasodilation rather than fluid retention, which means diuretics are not particularly effective in treating it, and dose reduction or switch to another agent is often the better clinical choice. [19]

Flushing, headache, and dizziness each occur in 2 to 7 percent of patients. [1] Serious adverse events are rare. Amlodipine does not cause the reflex tachycardia seen with shorter-acting dihydropyridines because its half-life of 30 to 50 hours produces a slow, smooth pharmacokinetic profile. [20] That long half-life also means a missed dose has less clinical impact than missing a dose of a twice-daily or thrice-daily antihypertensive.

Drug interactions worth noting for Alabama patients taking common comorbidity treatments: amlodipine plasma levels increase by roughly 40 percent when co-administered with simvastatin, prompting the FDA to cap simvastatin at 20 mg daily in patients taking amlodipine. [1] Cyclosporine co-administration also raises amlodipine levels. [20]

Practical Steps: Getting the Lowest Amlodipine Price in Alabama

Start by confirming whether your commercial plan lists generic amlodipine on Tier 1. If it does and your copay exceeds $8, ask the pharmacist to price the prescription through GoodRx before submitting to insurance. Many Alabama pharmacists can do this in under 60 seconds and are permitted to give you the lower price. [4]

If you are uninsured, use GoodRx, RxSaver, or the Walmart $4 Rx program. These bring the 30-day cost of 5 mg or 10 mg amlodipine to $4 to $8 at virtually every major chain in Alabama, including CVS, Walgreens, Winn-Dixie pharmacy, and Publix. [3]

If you are on Alabama Medicaid and your prescriber believes amlodipine is medically necessary, request a prior authorization. Document the preferred-agent trial, duration, and reason for switching. Approval rates for PAs citing intolerable edema on a diuretic or contraindication to beta-blockers are generally favorable. [5]

If you are interested in compounded amlodipine, a telehealth consultation with a HealthRX provider can determine whether a 503A compound is clinically appropriate for your situation. The prescription must be patient-specific and must reflect a documented clinical need distinct from the commercial tablet. [10, 11]

Patients over 65 on Medicare Part D should verify their plan's 2026 formulary before assuming Tier 1 placement carries over from prior years; plan formularies reset each January and can shift tier assignments without prior notice to the member. The Medicare Plan Finder tool at CMS.gov allows side-by-side formulary comparison. [14]